Wells Fargo’s Vaccinex, Inc. Common Stock VCNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2
| Closed | -$7 | – | 7264 |
|
|
2024
Q3 | $7 | Hold |
2
| – | – | ﹤0.01% | 6724 |
|
|
2024
Q2 | $13 | Sell |
2
-6
| -75% | -$36 | ﹤0.01% | 6602 |
|
|
2024
Q1 | $59 | Buy |
8
+3
| +60% | +$26 | ﹤0.01% | 6783 |
|
|
2023
Q4 | $45 | Buy |
5
+2
| +67% | +$24 | ﹤0.01% | 6954 |
|
|
2023
Q3 | $42 | Buy |
3
+2
| +200% | +$102 | ﹤0.01% | 6966 |
|
|
2023
Q2 | $89 | Hold |
1
| – | – | ﹤0.01% | 6900 |
|
|
2023
Q1 | $77 | Hold |
1
| – | – | ﹤0.01% | 6996 |
|
|
2022
Q4 | $122 | Hold |
1
| – | – | ﹤0.01% | 6749 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7568 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7684 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 8019 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | +$361 | ﹤0.01% | 7973 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7667 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7601 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7525 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7157 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7050 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6959 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6952 |
|
Other funds holding VCNX
Wells Fargo's VCNX Position: Q4 2024 in Review
Wells Fargo sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2024, closing a stake of 2 shares — an estimated $7 sold.
Wells Fargo first reported a position in VCNX in Q4 2021 and held it in 12 quarters. The position peaked at $122 in Q4 2022. 1 fund tracked by Wall St. Rank holds VCNX as of Q4 2024.
- Wells Fargo reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Wells Fargo sold 2 Vaccinex, Inc. Common Stock shares in Q4 2024, an estimated $7.
- Wells Fargo first reported a position in Vaccinex, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
- Wells Fargo's Vaccinex, Inc. Common Stock position peaked at $122 in Q4 2022.
- 1 fund tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2024.
Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.